United Orthopedic Corporation (TPEX: 4129)

Market Cap	9.46B
Revenue (ttm)	4.47B
Net Income (ttm)	449.61M
Shares Out	96.28M
EPS (ttm)	4.72
PE Ratio	20.80
Forward PE	16.78
Dividend	4.00 (4.08%)
Ex-Dividend Date	Jul 18, 2024

Volume	121,101
Open	98.50
Previous Close	97.80
Day's Range	98.50 - 100.50
52-Week Range	82.40 - 114.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About United Orthopedic

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fracture, Moore hip prosthesis, and customized artificial hip joints for individual tumor patients; artificial knee joint, such as artificial knee replacement joint, revision knee replacement system, restricted artificial knee joints, and customized artificial knee joints for individual tumor patients; and spine produ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4129

Financial Performance

In 2023, United Orthopedic's revenue was 3.93 billion, an increase of 24.02% compared to the previous year's 3.17 billion. Earnings were 379.62 million, an increase of 71.36%.